Concepedia

Charles Gleason

CG

Statistics

Publications

18

Citations

2.4K

H-Index

14

Active since

2021

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of Washington

Infectious Disease Research Institute

James J. Peters VA Medical Center

Charles Gleason is an author at Icahn School of Medicine at Mount Sinai specializing in immunology, vaccination, and sars-cov-2 infection.

ORCID

Publications per year

2021–2024

18

Publications

18

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer, Komal Srivastava, Hala Alshammary et al. · New England Journal of Medicine · 2021 · 803 citations · Full text

, , +16

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Juan Manuel Carreño, Hala Alshammary, Johnstone Tcheou et al. · Nature · 2021 · 532 citations

, , +11

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Fatima Amanat, Mahima Thapa, Tinting Lei et al. · Cell · 2021 · 313 citations · Full text

, , +14

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

Kaori Sano, Disha Bhavsar, Gagandeep Singh et al. · Nature Communications · 2022 · 166 citations · Full text

, , +17

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Komal Srivastava, Juan Manuel Carreño, Charles Gleason et al. · Immunity · 2024 · 137 citations · Full text

, , +17

1–5 of 18